A personalized cancer vaccine is already on the horizon
An alliance between two major pharmaceutical companies is bringing a promising proposal out of the lab: a personalized cancer vaccine. Although the alternative, for many, is still experimental, NEC Bio Therapeutics and AGC Biologica are betting on its possibilities. Did you know that Bristol-Myers Squibb’s drug Opdivo is estimated to sell more than $11 billion … Read more